221 related articles for article (PubMed ID: 36761755)
1. Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid.
Gao Y; Qian H; Hashimoto T; Li X
Front Immunol; 2023; 14():1118846. PubMed ID: 36761755
[TBL] [Abstract][Full Text] [Related]
2. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
3. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
[TBL] [Abstract][Full Text] [Related]
6. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
8. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.
Xie YH; Wang SH; Li SZ; Zuo YG
Front Immunol; 2022; 13():839094. PubMed ID: 35317170
[TBL] [Abstract][Full Text] [Related]
10. Brunsting-Perry pemphigoid: a systematic review.
Aromolo IF; Maronese CA; Moltrasio C; Genovese G; Marzano AV
Int J Dermatol; 2022 Nov; 61(11):1353-1358. PubMed ID: 35049061
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases.
Ohata C; Ishii N; Koga H; Fukuda S; Tateishi C; Tsuruta D; Furumura M; Hashimoto T
J Am Acad Dermatol; 2015 Jul; 73(1):50-5. PubMed ID: 25896671
[TBL] [Abstract][Full Text] [Related]
12. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
13. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract][Full Text] [Related]
15. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
17. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.
Goletz S; Pigors M; Lari TR; Hammers CM; Wang Y; Emtenani S; Aumailley M; Holtsche MM; Stang FH; Weyers I; König IR; Has C; Radzimski C; Komorowski L; Zillikens D; Schmidt E
J Am Acad Dermatol; 2024 Apr; 90(4):790-797. PubMed ID: 37992812
[TBL] [Abstract][Full Text] [Related]
18. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
19. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis.
Yamada T; Suzuki M; Koike Y; Kida K; Murata S; Ishii N; Hashimoto T; Ohtsuki M
Dermatology; 2006; 212(4):381-4. PubMed ID: 16707891
[TBL] [Abstract][Full Text] [Related]
20. [Rare variants of pemphigoid diseases].
Yilmaz K; Kiehne C; Holtsche MM; Schmidt E
Dermatologie (Heidelb); 2022 Dec; 74(12):937-947. PubMed ID: 37847383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
